MRI Contrast Agent Reduce Side Effects | MRI
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
MRI MRI Contrast Agent Reduce Side Effects

MRI Contrast Agent Reduce Side Effects

Radiology News

One woman’s ordeal with magnetic resonance imaging ( MRI ) contrast side effects may have changed how UK doctors use gadolinium-based contrast agents.

The woman, who is now confined to a wheelchair, has filed a lawsuit against the maker of the agent. Margaret Roxburgh, a 54-year-old grandmother in the UK, was given Omniscan prior to a routine magnetic resonance angiogram (MRA) scan, according to the Sunday Mail on 1/31/10. MRA scans, like magnetic resonance imaging ( MRI ) scans, provide images of the blood vessels inside the body.

Within 24 hours of the injection, Roxburgh suffered hot pains and her legs swelled to twice their normal size. Her hair fell out a few days after the procedure, and she was diagnosed with Nephrogenic Systemic Fibrosis (NSF). Roxburgh now uses a wheelchair and has been told that she may die from her condition.

She has filed a lawsuit against GE Healthcare Ltd. and GE Healthcare UK Ltd., both subsidiaries of General Electric.

Doctors in the UK have since been told not to give the contrast agent to anyone with severe kidney problems.

Study says, Adverse reactions to contrast agents are rare but serious.

The previous study published in American Journal of Roentgenology, the risks of serious adverse reactions to gadolinium-based MRI contrast agents. The study examined data from quality assurance records on the number of administrations of and acute adverse reactions to the contrast agents in patients who underwent MRIs. Researchers looked at approximately 32,600 instances of gadolinium exposure, of which 51 caused acute adverse reactions in 50 patients. Forty-three of those were mild, six were moderate and two were severe.

Researchers noted that severe adverse reactions are rare, but that radiologists and patients should be aware of the risk of using gadolinium-based contrast agents. So far, researchers believe the risk of developing NSF is highest in patients who suffer from decreased kidney function.

Source: LawyersandSettlements.com

Discuss more about MRI in the MRI user group.

 

Related Articles

Breaking News